Free Newsletter
FEATURES >> The most interesting logos in Pharma
Sanofi to build vaccine plant in China
Vaccines made in China--for China. Sanofi Pasteur says it's spending about $104 million on a Chinese manufacturing plant in hopes of launching flu shots locally by 2012. The plant will be in Shenzhen, South China, where the company already operates a filling and packing facility. Construction on the plant will start next year. When it's up and running, it will have 100 employees and a capacity of 25 million doses, but Sanofi hopes to double that within 10 to 15 years.
- read the report from Dow Jones
Related Articles:
Sanofi signs stem cell pact in China. Report
Sanofi vaccine effective against new bird flu strains. Report
China pushes drug development as R&D soars. Report
More stories about drug development
Comments
Post new comment
Paid Research Reports
- Cloud Computing Adoption In The APAC Life Sciences Industry
- Pharmaceutical Licensing Overview
- Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina
- Pharmaceutical Key Trends 2010
- Commercial Insight: Top 20 Oncology Therapy Brands in Australia
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities



SHARE
WITH: